Clinical trial

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung…

NCT00136864 · Ontario Clinical Oncology Group (OCOG), Other · Completed

Key facts

NCT number NCT00136864
Title Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)
Official title The Impact of Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer: A Prospective Randomized Clinical Trial (PET START Trial)
Lead sponsor Ontario Clinical Oncology Group (OCOG), Other
Collaborators Ontario Ministry of Health and Long Term Care
Status Completed
Phase Phase 3
Study type Interventional
Conditions Non-Small-Cell Lung Carcinoma
Intervention type Procedure
Interventions PET Diagnostic Imaging
Enrollment 310
Start date Aug 1, 2004
Primary completion Nov 1, 2009
Completion Sep 1, 2011
First posted Aug 29, 2005
Last update posted Nov 18, 2011
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies